Eric Barker
Eric Barker
Geverifieerd e-mailadres voor purdue.edu
Geciteerd door
Geciteerd door
Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands.
EL Barker, RS Westphal, D Schmidt, E Sanders-Bush
Journal of Biological Chemistry 269 (16), 11687-11690, 1994
Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor
JE Burdette, J Liu, S Chen, DS Fabricant, CE Piersen, EL Barker, ...
Journal of Agricultural and Food Chemistry 51 (19), 5661-5670, 2003
Norepinephrine and serotonin transporters: molecular targets of antidepressant drugs
EL Barker, RD Blakely
Psychopharmacology: the fourth generation of progress 28, 321-333, 1995
Transmembrane domain I contributes to the permeation pathway for serotonin and ions in the serotonin transporter
EL Barker, KR Moore, F Rakhshan, RD Blakely
Journal of Neuroscience 19 (12), 4705-4717, 1999
Serotonin 5-hydroxytryptamine2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reserves
DM Kurrasch-Orbaugh, VJ Watts, EL Barker, DE Nichols
Journal of Pharmacology and Experimental Therapeutics 304 (1), 229-237, 2003
Cloning, expression, and localization of a chloride-facilitated, cocaine-sensitive serotonin transporter from Drosophila melanogaster.
LL Demchyshyn, ZB Pristupa, KS Sugamori, EL Barker, RD Blakely, ...
Proceedings of the National Academy of Sciences 91 (11), 5158-5162, 1994
High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis: an aromatic residue in transmembrane domain I dictates species-selective …
EL Barker, MA Perlman, EM Adkins, WJ Houlihan, ZB Pristupa, HB Niznik, ...
Journal of Biological Chemistry 273 (31), 19459-19468, 1998
Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide
TA Day, F Rakhshan, DG Deutsch, EL Barker
Molecular Pharmacology 59 (6), 1369-1375, 2001
D2 dopamine receptors modulate Gα-subunit coupling of the CB1 cannabinoid receptor
A Jarrahian, VJ Watts, EL Barker
Journal of Pharmacology and Experimental Therapeutics 308 (3), 880-886, 2004
Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells
F Rakhshan, TA Day, RD Blakely, EL Barker
Journal of Pharmacology and Experimental Therapeutics 292 (3), 960-967, 2000
A role for caveolae/lipid rafts in the uptake and recycling of the endogenous cannabinoid anandamide
MJ McFarland, AC Porter, FR Rakhshan, DS Rawat, RA Gibbs, EL Barker
Journal of Biological Chemistry 279 (40), 41991-41997, 2004
Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines
JB Blair, D Kurrasch-Orbaugh, D Marona-Lewicka, MG Cumbay, VJ Watts, ...
Journal of medicinal chemistry 43 (24), 4701-4710, 2000
Identification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing.
H Canton, RB Emeson, EL Barker, JR Backstrom, JT Lu, MS Chang, ...
Molecular pharmacology 50 (4), 799-807, 1996
Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands.
EL Barker, HL Kimmel, RD Blakely
Molecular pharmacology 46 (5), 799-807, 1994
Assessing Cholesterol Storage in Live Cells and C. elegans by Stimulated Raman Scattering Imaging of Phenyl-Diyne Cholesterol
HJ Lee, W Zhang, D Zhang, Y Yang, B Liu, EL Barker, KK Buhman, ...
Scientific reports 5 (1), 7930, 2015
Anandamide transport
MJ McFarland, EL Barker
Pharmacology & therapeutics 104 (2), 117-135, 2004
Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter.
EL Barker, RD Blakely
Molecular Pharmacology 50 (4), 957-965, 1996
Interactions of tryptamine derivatives with serotonin transporter species variants implicate transmembrane domain I in substrate recognition
EM Adkins, EL Barker, RD Blakely
Molecular pharmacology 59 (3), 514-523, 2001
Serotonin transporters: implications for antidepressant drug development
KJ White, CC Walline, EL Barker
Drug Addiction: From Basic Research to Therapy, 193-215, 2008
5-hydroxytryptamine1C receptor density and mRNA levels in choroid plexus epithelial cells after treatment with mianserin and (-)-1-(4-bromo-2, 5-dimethoxyphenyl)-2-aminopropane.
EL Barker, E Sanders-Bush
Molecular pharmacology 44 (4), 725-730, 1993
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20